Monday, November 23, 2009

DARA BioSciences Presented Results of Its Phase 2 Study for KRN5500 at the "12th International Conference on th.. http://bit.ly/07dVHXy
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)